Finance

Lists
Why is ACET down 2.01%?
Dive Deeper
ACET:NASDAQ
Adicet Bio Inc
$2.93
-2.01%
(-0.060) 1D
$2.93
0.00% (0.00)
After hours
Closed: Nov 12, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACET...
Open
$2.96
High
$3.08
Low
$2.84
Mkt. cap
27.43M
Avg. vol.
227.82K
Volume
0.00
52-wk high
$11.20
52-wk low
$2.84
EPS
-$10.06
Beta
1.69
Shares outstanding
9.36M
No. of employees
102
Open
$2.96
High
$3.08
Low
$2.84
Mkt. cap
27.43M
Avg. vol.
227.82K
Volume
0.00
52-wk high
$11.20
52-wk low
$2.84
EPS
-$10.06
Beta
1.69
Shares outstanding
9.36M
No. of employees
102
News stories
From web sources and news partners
About Adicet Bio Inc
CEO-
Employees102
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to ACET in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACET in the last 3 months.
Highest
Current $2.93
$55.00 (+1,777.13%)
Average
$31.00 (+958.02%)
Lowest
$18.00 (+514.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
$20.00
+582.6%
11/06/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$34.00
+1,060.4%
11/06/2026
John Newman
Canaccord Genuity
Buy
Maintained
$18.00
+514.3%
11/06/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$28.00
+855.6%
11/06/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$55.00
+1,777.1%
11/05/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$25.00
+753.2%
08/06/2026
Anthea Li
Jefferies
Buy
Initiated
$19.00
+548.5%
05/04/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+582.6%
04/06/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
-
-
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.04M
17.49M
18.45M
15.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.85M
4.08M
3.85M
4.17M
Operating expense
31.89M
21.57M
22.30M
19.80M
Total operating expenses
31.89M
21.57M
22.30M
19.80M
Operating income
-31.89M
-21.57M
-22.30M
-19.80M
Other non operating income
-130.00K
7.00K
-60.00K
-30.00K
EBT including unusual items
-30.52M
-20.24M
-21.22M
-18.88M
EBT excluding unusual items
-30.52M
-20.24M
-21.22M
-18.88M
Income tax expense
-
-
143.00K
1.00K
Effective tax rate
-
-
-0.67%
-0.01%
Other operating expenses
-
-
-
-
Net income
-30.52M
-20.24M
-21.36M
-18.88M
Net profit margin
-
-
-
-
Earnings per share
-2.94
-1.88
-1.99
-1.76
Interest and investment income
1.52M
1.34M
1.17M
972.00K
Interest expense
-24.00K
-23.00K
-22.00K
-23.00K
Net interest expenses
1.50M
1.32M
1.15M
949.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.41M
-20.23M
-21.10M
-18.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps